Clinical trial
Study of Metabolites Markers in Adjuvant Breast Cancer
NCT03367208 is registered in ClinicalTrials.gov with Centre Antoine Lacassagne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Metabolites Markers in Adjuvant Breast Cancer
- Lead sponsor
- Centre Antoine Lacassagne
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 12, 2017
- Completion date
- May 23, 2017
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.